Related by context. All words. (Click for frequent words.) 73 virus HCV protease inhibitor 73 Carfilzomib 72 mapatumumab 72 PRT# 72 sorafenib Nexavar 72 temsirolimus 72 ritonavir boosted 72 oral prodrug 72 BAY #-# 72 Traficet EN 71 Boceprevir 71 evaluating tivozanib 71 phase IIb clinical 71 Pegasys ® 71 Dasatinib 71 erlotinib Tarceva ® 71 docetaxel Taxotere ® 71 AEGR 70 investigational humanized monoclonal antibody 70 rNAPc2 70 oral rivaroxaban 70 pomalidomide 70 Dapagliflozin 70 subcutaneously administered 70 visilizumab 70 ZD# [001] 70 Tarceva TM 70 sorafenib tablets 70 docetaxel Taxotere R 70 nitazoxanide 69 nucleoside analog 69 DU #b 69 pegylated interferon alfa 2a 69 teriflunomide 69 cilengitide 69 administered subcutaneously 69 investigational protease inhibitor 69 JAK inhibitor 69 adalimumab Humira 69 Phase Ib clinical 69 oral antiviral 69 dexamethasone Decadron 69 active comparator 69 mTOR inhibitor 69 thalidomide Thalomid 69 proteasome inhibitor 69 FOLFOX6 chemotherapy regimen 69 multicenter Phase III 69 immunomodulator 69 Tyrima 69 AEG# 69 fosbretabulin 69 mertansine 69 ceftazidime 69 Lacosamide 69 TELINTRA 69 Cethromycin 69 Rivaroxaban 69 metaglidasen 69 ixabepilone 69 YONDELIS 68 Aflibercept 68 receptor tyrosine kinase inhibitor 68 ongoing Phase 1b 68 Golimumab 68 paclitaxel Taxol 68 ZOLINZA 68 PDE4 inhibitor 68 CIMZIA TM 68 CA4P 68 investigational oral 68 GW# [003] 68 blinded randomized placebo controlled 68 axitinib 68 lapatinib Tykerb 68 inhibitor RG# 68 Pharmacokinetics PK 68 pan HDAC inhibitor 68 HCV SPRINT 68 vinca alkaloid 68 HGS# 68 Sym# 68 eltrombopag 68 ribavirin RBV 68 ganetespib 68 PREZISTA r 68 Lubiprostone 68 angiotensin receptor blocker ARB 68 posaconazole 68 pertuzumab 68 Vandetanib 68 APTIVUS r 68 metastatic renal cell carcinoma 68 pegylated interferon alpha 68 reslizumab 68 Sapacitabine 68 bendamustine 68 Bezielle 68 riociguat 68 Bortezomib 67 Mipomersen 67 Nexavar ® 67 tocilizumab 67 casopitant 67 Pazopanib 67 PSN# [002] 67 histone deacetylase inhibitor 67 CD# monoclonal antibody 67 Aliskiren 67 CG# [003] 67 neratinib 67 alfa 2a 67 INCB# [001] 67 angiogenesis inhibitor 67 nab paclitaxel 67 forodesine 67 Blinatumomab 67 abacavir lamivudine 67 Amrubicin 67 bevacizumab Avastin ® 67 CCX# 67 vascular disrupting agent 67 IMA# 67 liposomal formulation 67 Pegasys R 67 TG# [003] 67 ADP receptor antagonist 67 inhaled corticosteroid ICS 67 BMS # 67 CCR5 antagonist 67 MAGE A3 ASCI 67 TMC# C# 67 viral kinetics 67 Phase Ib 67 somatostatin analogue 67 direct thrombin inhibitors 67 Valsartan 67 Laquinimod 67 Vidaza azacitidine 67 alefacept 67 Phase 1b trial 67 APTIVUS 67 TLK# 67 raltegravir 67 thymalfasin 67 Pemetrexed 67 celgosivir 67 Maribavir 67 beta2 agonist 67 sunitinib malate 67 peginterferon alfa 2b 67 DAVANAT 67 VAPRISOL 67 FOLFOX6 67 antiplatelet agent 67 Glufosfamide 67 NXL# 67 relapsed refractory multiple myeloma 67 NVA# 67 tolerability pharmacokinetics 67 regorafenib 67 subcutaneous formulation 67 phase Ib 67 Imprime PGG 67 OncoVEX GM CSF 67 Triapine 67 PRTX 67 pharmacokinetics PK 67 telaprevir VX 67 Dalbavancin 67 pharmacodynamic properties 66 orally bioavailable 66 CBLC# 66 olmesartan 66 glatiramer acetate 66 PD LID 66 CCX# B 66 dosing regimens 66 Pertuzumab 66 systemically administered 66 gemcitabine Gemzar 66 multi kinase inhibitor 66 Aclidinium 66 phase IIa clinical 66 integrase inhibitor 66 elvitegravir 66 Hsp# Inhibitor 66 desvenlafaxine succinate 66 histone deacetylase HDAC inhibitor 66 sodium glucose cotransporter 66 mRCC 66 bortezomib Velcade R 66 Teriflunomide 66 elotuzumab 66 Tezampanel 66 CEQ# 66 Phase Ib II 66 PDX pralatrexate 66 Methylnaltrexone 66 baminercept 66 ascending dose 66 Camptosar ® 66 orally administered inhibitor 66 tigecycline 66 Enzastaurin 66 Albuferon TM 66 Xanafide 66 rilonacept 66 Elagolix 66 PEGINTRON TM 66 ACTEMRA TM 66 PKC# 66 MEK inhibitor 66 HGS ETR1 66 fluticasone furoate 66 safety tolerability pharmacokinetic 66 muraglitazar 66 mycophenolate mofetil 66 cediranib 66 atrasentan 66 HuMax EGFr 66 PEG interferon 66 HGS ETR2 66 dasatinib Sprycel ® 66 CYT# potent vascular disrupting 66 tenofovir Viread 66 PEG SN# 66 PXD# 66 neuraminidase inhibitor 66 Adalimumab 66 sorafenib Nexavar ® 66 HuMax CD4 66 volociximab 66 Panzem R NCD 66 Ambrisentan 66 PegIFN 66 vidofludimus 66 TO AVOID PREGNANCY WHILE 66 Darunavir 66 serotonin norepinephrine reuptake inhibitor 66 BAL# [002] 66 tipranavir 66 Tekamlo 66 paclitaxel poliglumex 66 maximally tolerated dose 66 edoxaban 66 Afatinib 66 primary hypercholesterolemia 66 novel oral anticoagulant 66 peripherally acting 66 Irinotecan 66 ISENTRESS 66 preclinical efficacy 66 vorinostat 66 HCV protease inhibitors 66 telcagepant 66 HCV NS5B polymerase 66 boosted protease inhibitor 66 pegylated interferons 66 tanespimycin 66 HCV protease inhibitor 66 Omacetaxine 66 peginterferon alfa 2a 66 Phase 1b clinical 66 galiximab 66 radezolid 66 LEXIVA r 66 Omacetaxine mepesuccinate 66 microtubule inhibitor 66 ENMD # 66 velafermin 66 relapsed MM 66 AZILECT R 66 pegylated liposomal doxorubicin 66 lacosamide 66 KRN# 66 nucleoside reverse transcriptase inhibitor 66 double blinded placebo 66 vicriviroc 66 Tanespimycin 66 Factor Xa inhibitor 66 bortezomib Velcade 66 selective modulator 66 DAPT 65 BRAF inhibitor 65 infliximab Remicade 65 Mitoxantrone 65 oral renin inhibitor 65 IFN α 65 Tipranavir 65 prokinetic agent 65 SRT# [003] 65 Targretin 65 canagliflozin 65 BENLYSTA ® 65 Phase Ib clinical trials 65 Vilazodone 65 tyrosine kinase inhibitor 65 decitabine 65 octreotide acetate 65 protein kinase inhibitor 65 refractory gout 65 pharmacodynamic profile 65 tenofovir emtricitabine 65 investigational hepatitis C 65 tolerability 65 lomitapide 65 Androxal TM 65 perampanel 65 lumiliximab 65 depsipeptide 65 Noxafil 65 REG1 65 dasatinib Sprycel 65 polymerase inhibitor 65 zileuton 65 olaparib 65 standard chemotherapy regimen 65 ribavirin USP 65 kinase inhibitor 65 interferon alfa 65 antiarrhythmic 65 Romidepsin 65 NOXAFIL 65 placebo controlled clinical 65 favorable pharmacokinetic profile 65 investigational monoclonal antibody 65 long acting beta2 65 gefitinib Iressa 65 docetaxel chemotherapy 65 ALGRX 65 insulin sensitizers 65 LY# [003] 65 enzastaurin 65 ascending doses 65 interferon alfa 2b 65 Phase 2a trial 65 ALN HPN 65 albiglutide 65 trastuzumab Herceptin 65 Panzem R 65 Phase 1a clinical 65 #I TM# 65 AP# [003] 65 small molecule Hedgehog 65 GSK# [002] 65 monotherapy 65 alkylating agent 65 targeted antifolate 65 anti leukemic 65 dose cohorts 65 tipifarnib 65 anti CD3 antibody 65 carfilzomib 65 invasive candidiasis 65 Randomized Double blind 65 trabectedin 65 pain palliation 65 Radezolid 65 Phase #b/#a clinical 65 investigational compound 65 Eraxis 65 PegIntron 65 HGS ETR1 mapatumumab 65 amprenavir 65 Phase Ib study 65 Anidulafungin 65 chronic HCV infection 65 alvespimycin 65 long acting muscarinic 65 Apixaban 65 huN# DM1 65 TBC# 65 vandetanib 65 INVIRASE 65 Dabigatran etexilate 65 anticancer agent 65 LibiGel ® 65 dose regimens 65 cIAI 65 signal transduction inhibitor 65 intranasal formulation 65 HuLuc# 65 Muraglitazar 65 mg RDEA# 65 liposomal doxorubicin 65 selective agonist 65 cisplatin gemcitabine 65 Tofacitinib 65 echinocandin 65 CANCIDAS 65 Elotuzumab 65 Cloretazine 65 Meets Primary Endpoint 65 phase IIa 65 Epratuzumab 65 Nexavar sorafenib tablets 65 TG# [001] 65 Archexin 65 Daclizumab 65 etanercept Enbrel 65 Deforolimus 65 HDACi 65 darapladib 65 urate lowering 65 CorVue ™ 65 sunitinib Sutent ® 65 Erlotinib 65 atherothrombotic events 65 protease inhibitor PI 65 dosed orally 65 CERVARIX 65 Bosutinib 65 HCV protease 65 ARCOXIA 65 Tolvaptan 65 Vaprisol 65 SPC# [001] 65 PI3K inhibitor 65 davunetide intranasal AL 65 alpha 2b 65 atazanavir sulfate 65 antifibrotic 65 CIMZIA ™ 65 octreotide 65 5 Fluorouracil 65 solithromycin 65 Peg IFN 65 eprotirome 65 ZYBRESTAT 65 Velcade bortezomib 65 lexidronam injection 65 pharmacokinetic PK 65 peg interferon 65 aprepitant 65 PEG Interferon lambda 65 CRx 65 pemetrexed Alimta 65 ALK inhibitor 65 Pegylated Interferon 65 etravirine 65 Telavancin 65 cell lymphoma CTCL 65 acyclovir Lauriad R 65 lixisenatide 65 sorafenib 65 idarubicin 65 bevacizumab Avastin 65 INVANZ 64 Clolar ® 64 phase IIb trial 64 Peginterferon 64 romidepsin 64 HDAC Inhibitor 64 intravenously administered 64 pegylated interferon alfa 64 peginterferon alpha 2a 64 proteasome inhibitors 64 Sustiva efavirenz 64 tolerability profiles 64 Vicriviroc 64 Nexavar sorafenib 64 Symadex 64 Eltrombopag 64 metastatic castration resistant 64 pegylated 64 multicenter Phase II 64 cetuximab Erbitux R 64 Gefitinib 64 pharmacokinetic PK study 64 LEVAQUIN 64 FOLFIRI 64 gemcitabine 64 selective estrogen receptor modulator 64 alvimopan 64 Zolinza 64 dexpramipexole 64 PNP inhibitor 64 indinavir Crixivan 64 dextromethorphan quinidine 64 CTAP# Capsules 64 castrate resistant prostate cancer 64 Oral NKTR 64 mg QD 64 carboplatin paclitaxel 64 Capecitabine 64 Ridaforolimus 64 lucinactant 64 platelet inhibitor 64 highly selective endothelin 64 novel histone deacetylase 64 PF # [001] 64 panitumumab Vectibix 64 IMC A# 64 olanzapine Zyprexa 64 Iressa gefitinib 64 orally administered 64 zolmitriptan 64 TriRima 64 Phase 1b 64 Azedra 64 ULORIC 64 Sitagliptin 64 Serdaxin 64 Denufosol 64 diabetic neuropathic pain 64 metastatic hormone refractory 64 oral ridaforolimus 64 pan histone deacetylase 64 relapsed multiple myeloma 64 Copegus ribavirin 64 mitomycin 64 Protease Inhibitor 64 Telbivudine 64 Perifosine 64 Melphalan 64 VA# [002] 64 TMC# [001] 64 ocular formulation 64 BENICAR HCT 64 OMP #M# 64 azacitidine 64 Randomized Phase 64 Trandolapril 64 Doxil ® 64 sitagliptin 64 miconazole Lauriad ® 64 chlorambucil 64 antithrombotic 64 INTELENCE 64 Vernakalant 64 intravenous dosing 64 anticancer compound 64 goserelin 64 vemurafenib 64 PEGASYS ® 64 tecarfarin 64 eosinophilic asthma 64 azacytidine 64 Telmisartan 64 MEK inhibitors 64 Peginterferon Alfa 2a 64 Ceflatonin R 64 obatoclax 64 nucleotide analogue 64 ISTODAX 64 oral proteasome inhibitor 64 GSK# [001] 64 cariprazine 64 diarrhea predominant irritable 64 mu opioid receptor antagonist 64 Alfimeprase 64 ibandronate 64 dabigatran etexilate 64 interferon gamma 1b 64 Pradefovir 64 non peptidic protease 64 mg TID 64 FOLOTYN ® 64 antitumor activity 64 hour bronchodilation 64 AAG geldanamycin analog 64 metastatic HRPC 64 antithrombotics 64 Phase IIb Trial 64 Atripla combines 64 ulimorelin 64 cidofovir 64 Fludara ® 64 Ozarelix 64 oral deforolimus 64 bevacizumab Avastin R 64 transcriptase inhibitor NNRTI 64 SAR# [004] 64 peg IFN 64 adalimumab 64 HFA MDI 64 Sorafenib 64 Acute Ischemic Stroke 64 Nanobody 64 Gemcitabine 64 fluoroquinolone antibiotic 64 PS# [001] 64 Xeloda ® 64 TREDAPTIVE 64 micafungin 64 Epirubicin 64 gefitinib 64 fenofibric acid 64 investigational pharmacologically unique 64 HQK 64 Safinamide 64 LymphoStat B 64 deforolimus 64 Taxotere ® 64 Atrasentan 64 Ribavirin 64 certolizumab 64 lamivudine 3TC 64 pegylated alpha interferon 64 CD4 monoclonal antibody 64 ponatinib 64 AKT inhibitor 64 Pafuramidine 64 HCV RESPOND 2 64 bicifadine 64 selective inhibitor 64 methylnaltrexone bromide 64 Epivir 64 Initiated Phase 64 PEG IFN 64 prucalopride 64 Pegasys peginterferon alfa 2a 64 CR# vcMMAE 64 LY# [002] 64 MAP# 64 PEGylated anti 64 factor Xa inhibitor 64 SUTENT ® 64 indacaterol 64 albinterferon alfa 2b 64 preclinically 64 leukemia AML 64 generation purine nucleoside 64 FTY# fingolimod 64 S/GSK# 64 Diovan HCT 64 antiviral activity 64 non nucleoside inhibitor 64 Celebrex celecoxib 64 Phase 2b Clinical Trial 64 ZK EPO 64 Chemophase 64 Investigational Compound 64 HMG CoA reductase inhibitors 64 DEB# 64 Tarceva erlotinib 64 HSP# inhibitor 64 PEGylated Fab fragment 64 ZACTIMA 64 aripiprazole Abilify 64 investigational antiplatelet 64 PLX# 64 xenograft models 64 Zybrestat 64 GLPG# 64 Anthim 64 trodusquemine 64 Antiviral Activity 64 omega interferon 64 cetuximab Erbitux ® 64 Ophena TM 64 Vorinostat 64 Zoraxel 64 plus Copegus R 64 AGILECT ® 64 Vidofludimus 64 μg dose 64 Oral Fingolimod 64 Roche Pegasys 64 motesanib 64 DexaSite 64 TNF Tumor Necrosis Factor 64 orally dosed 64 Vfend 64 immunomodulatory therapy 64 CoFactor 64 raloxifene Evista 64 biologic DMARD 64 prospective randomized placebo 64 phase IIb study 64 Phase 2b Study 64 itraconazole 64 DORIBAX 64 CYT# 64 cathepsin K inhibitor 64 pegylated interferon alpha 2a 64 Phase 2a clinical 64 LAF# 64 cutaneous T 64 amrubicin 64 NOX E# 64 nelfinavir 64 Lixivaptan 64 intravesical instillation 64 iniparib 64 Gleevec resistant 64 methylnaltrexone 64 Firazyr 64 zoledronate 63 Linagliptin 63 erlotinib 63 alpha 2a 63 Lenocta 63 PEGylated interferon beta 1a 63 6R BH4 63 Talabostat 63 sulodexide 63 BRIM2 63 Solulin 63 LEP ETU 63 pharmacokinetic interactions 63 Universal Flu Vaccine 63 beta 1a 63 mg dose 63 antiarrhythmic drug 63 double blinded randomized 63 pharmacodynamic 63 Elvitegravir 63 L BLP# 63 ciclesonide 63 Interferon alpha 63 itraconazole Sporanox 63 abiraterone 63 Torisel 63 XmAb# 63 BARACLUDE R 63 daptomycin 63 SinuNase TM 63 Antitumor Activity 63 Emend 63 highly selective inhibitor 63 tezampanel 63 docetaxel 63 Rigel R# 63 refractory chronic lymphocytic 63 rituximab Rituxan 63 Plecanatide 63 Mg Usa 63 APOPTONE 63 RSD# 63 laropiprant 63 novel VDA molecule 63 Tesetaxel 63 TRANSFORMS 63 immunomodulating 63 SARMs 63 canakinumab 63 Romiplostim 63 aliskiren 63 non nucleoside 63 MKC# MKC# PP 63 QVA# 63 myopathy rhabdomyolysis 63 melphalan prednisone 63 dalbavancin 63 icatibant 63 Cetrorelix 63 ritonavir boosted atazanavir 63 biologic therapy 63 Pimavanserin 63 plus COPEGUS 63 dose escalation trial 63 multicenter randomized placebo controlled 63 TAFA# 63 Tocilizumab 63 vapreotide acetate 63 Phase 2b study 63 PI3K/Akt pathway inhibitor 63 treatment naive genotype 63 ISIS # 63 proton pump inhibitor PPI 63 Triolex 63 MEVACOR 63 TRX1 63 INGN 63 lead Aganocide compound 63 Darusentan 63 caspofungin 63 sunitinib 63 temsirolimus Torisel ® 63 torezolid 63 tumor xenograft models 63 delafloxacin 63 Ixempra 63 REMICADE ® 63 Avanafil 63 CIMZIA TM certolizumab pegol 63 docetaxel Taxotere 63 anidulafungin 63 Darinaparsin 63 dosing cohorts 63 INC# 63 Ceftaroline 63 Pivotal Phase 63 tasocitinib 63 Eculizumab 63 brivaracetam 63 maraviroc 63 PSMA ADC 63 doripenem 63 Multimeric 63 Aptivus ® 63 SAR# [002] 63 antiviral efficacy 63 Aptivus 63 Vimpat R 63 Cyclosporine 63 Phase 2a Clinical Trial 63 IMP# 63 RELOVAIR ™ 63 selective antagonist 63 trastuzumab Herceptin R 63 pegylated interferon 63 DFMO 63 5 FU leucovorin 63 cytokine refractory 63 Restanza 63 LymphoStat B TM 63 PEG INTRON R 63 ADVANCE PD 63 MEK Inhibitor 63 oral anticoagulant 63 VEGF receptor inhibitor 63 Abatacept 63 immunomodulatory 63 azilsartan medoxomil 63 Cytoxan 63 recurrent glioblastoma multiforme 63 pharmacodynamic effects 63 Phase #b/#a 63 Lenalidomide 63 aflibercept VEGF Trap 63 Vidaza R 63 nucleotide analog 63 telaprevir dosed 63 Alinia 63 Cloretazine ® 63 reverse transcriptase inhibitors 63 cangrelor 63 cancer neuroendocrine tumor 63 pramlintide 63 angiotensin II receptor blocker 63 Belimumab 63 Calcitonin 63 LEVAQUIN ® 63 lesinurad 63 #mg BID [003] 63 QLT# 63 REYATAZ R 63 pharmacodynamics PD 63 pregabalin Lyrica 63 acetonide FA 63 thiazolides 63 investigational compounds 63 MGd 63 Oral Insulin 63 Telaprevir VX 63 Randomized Double Blind 63 PROVENGE ® 63 Perforomist ™ Inhalation Solution 63 TYGACIL 63 clevidipine 63 mg/m2 administered 63 neuroprotectant 63 aspirin clopidogrel 63 Peginterferon alfa 2b 63 hypoxia activated prodrug 63 TMC# r 63 Bevacizumab 63 Pralatrexate 63 LHRH antagonists 63 clobazam 63 Exenatide 63 IAP inhibitors 63 ceftaroline 63 AZT zidovudine Retrovir 63 crizotinib PF # 63 ALVESCO 63 tacrolimus ointment 63 Ticagrelor 63 Fingolimod 63 CHOP chemotherapy 63 GRN#L 63 Orally administered 63 Tasimelteon 63 gastrointestinal stromal tumors GIST 63 dyskinesia PD LID 63 PrandiMet TM 63 DermaVir Patch 63 IRX 2 63 MIRCERA 63 tyrosine kinase inhibitor TKI 63 nicardipine 63 Simulect 63 PrevOnco ™ 63 insulin sensitizing 63 azoles 63 rilpivirine 63 IAP inhibitor 63 valopicitabine 63 octreotide LAR 63 Elesclomol 63 Complicated Skin 63 Silodosin 63 anti amnesic 63 unfractionated heparin UFH 63 XL# [003] 63 RGB # 63 pioglitazone 63 JAK Inhibitor 63 efficacy tolerability 63 Phase 2b clinical trials 63 pitavastatin 63 tolerability profile 63 erlotinib Tarceva 63 dosage regimens 63 SPRYCEL ® 63 TELCYTA 63 paliperidone ER 63 Icatibant 63 TYZEKA 63 Zenvia ™ 63 Degarelix 63 Herceptin trastuzumab 63 zalutumumab 63 leukotriene receptor antagonists 63 protease inhibitors PIs 63 2 methoxyestradiol 63 ZYVOX 63 refractory CLL 63 ISENTRESS raltegravir 63 CYT# QbG# 63 MabCampath 63 alicaforsen enema 63 nilotinib 63 Catena ® 63 Onconase 63 Febuxostat 63 Seliciclib 63 imetelstat 63 PHX# 63 oral Janus kinase 63 zonisamide SR 63 familial amyloidotic polyneuropathy FAP 63 advanced hepatocellular carcinoma 63 AVASTIN 63 eritoran 63 virus HCV infection 63 Ranolazine 63 severe gastroparesis 63 HspE7 63 antiplatelet compound 63 AVE# 63 Amplimexon 63 mcg kg 63 oral salmon calcitonin 63 odanacatib 63 Clevudine 63 Quinamed 63 synthetic retinoid 63 estramustine 63 heparins 63 MGCD# [001] 63 opioid induced bowel dysfunction 63 oral nucleoside analogue 63 Aplidin R 63 valsartan 63 TYKERB 63 Inhalation Solution 63 assessing T DM1 63 XL# XL# 63 LymphoStat B belimumab 63 relapsing multiple sclerosis 63 lenalidomide dexamethasone 63 histamine dihydrochloride 63 DOXIL 63 mixed dyslipidemia 63 Erbitux cetuximab 63 Protelos 63 Voreloxin 63 Initiate Phase 63 BROVANA 63 Fludara 63 SERMs 63 fumarate 63 oral antifungal 63 vismodegib 63 dacarbazine 63 treatment naïve genotype 63 boceprevir 63 Enhanze Technology 63 IDX# 63 TEMODAL 63 paroxetine Paxil 63 lenalidomide Revlimid ® 63 R roscovitine 63 amphotericin B 63 Liraglutide 62 talabostat 62 targeting CD# 62 anakinra 62 R sorafenib tablets 62 COPEGUS 62 torezolid phosphate 62 immunotherapeutic agent 62 alpha blocker 62 Known generically 62 BARACLUDE ®